Top Markets
Coin of the day
Staidson (Beijing) BioPharmaceuticals Co., Ltd. Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Staidson (Beijing) BioPharmaceuticals Co., Ltd.

300204
Ранг среди акций #7949
Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical... Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical company that specializes in the entire lifecycle of therapeutic drugs, from research and development to production and market distribution. Their product portfolio encompasses a variety of drug types, including advanced protein-based medicines like therapeutic monoclonal antibodies, innovative gene and cell therapies, and conventional chemical pharmaceuticals. The company's primary therapeutic areas address conditions related to the nervous system, infectious diseases, gastrointestinal health, the urinary system, and autoimmune disorders. Notably, Staidson has established a strategic partnership with Pivotal S.L. to conduct clinical trials in Europe for BDB-001, a monoclonal anti-C5a antibody, aimed at treating patients with severe, progressive COVID-19 caused by the SARS-CoV-2 virus. Founded in 2002, the company's headquarters are located in Beijing, China.
Цена акции
$3.11
Рыночная капитализация
$1.41B
Изменение (1 день)
-1.97%
Изменение (1 год)
-57.22%
Страна
CN
Торговля Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)

Категория

Коэффициент P/B для Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Staidson (Beijing) BioPharmaceuticals Co., Ltd., текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Staidson (Beijing) BioPharmaceuticals Co., Ltd. с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
3.7087 -
US
- -
CH